A High Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Does Not Impair Outcomes After Non-Myeloablative Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients 60 Years or Older

Researchers analyzed 289 AML patients 60 years or older undergoing non-myeloablative conditioning-hematopoietic stem cell transplantation. Hematopoietic cell transplantation comorbidity index risk was low, intermediate, or high in 36%, 31%, and 33% of patients, respectively.